TEL AVIV, Israel, July 24, 2017 /PRNewswire/ --
EZbra advanced wound care ltd, developer of a patented disposablepost-surgical breast dressing that provides soft absorbent protection and compression, announced today that Efrat Roman, founder and CEO, presented the company's story and flagship product to VCs and angel investors in
Every year, 13 million women worldwide undergo various types of breast procedures and surgeries, for either medical or aesthetic reasons, and yet, there is no standard of care addressing all these women post-op.
The company's flagship product, EZbra, is a medical device, all in one advanced breast dressing, proprietary sterile and disposable bra, offering a state of the art solution, for the discomfort and inefficiencies post-op patients experience with current breast wound dressings.
EZbra is designed for patient's maximum independency while replacing dressings, it will fit itself perfectly to any breast formation it covers, absorb wound exudates, apply various amounts of compression, anchor implants and stabilize drains, while allowing patients to recover with dignity.
EZbra is part of the emerging FemTech industry which focuses on women's healthcare and wellness. Company's Founder and CEO Efrat Roman is a breast cancer survivor and the founder of CureDiva.com, the 1st social-commerce website for women dealing with breast cancer.
"The inspiration for EZbra was born of my own personal fight with breast cancer, where I discovered the inadequacies of the existing post-op bandages. To date we've successfully raised $2 million in seed funding and are seeking new investors and strategic partners from the healthcare and wellness sector for our next round to provide added value for the EZbra launch in 2018," said Efrat Roman, CEO.
EZbra aspires to create a uniformly accepted high-quality breast dressing for the over 13 million women who undergo various types of breast procedures and surgeries annually. The company's flagship product, is an innovative and patented disposable post-surgical breast dressing that provides soft absorbent protection and compression. To date the company has raised $2 million and is headquartered in Tel Aviv.
Contact: Amalia Herszkowicz email@example.com +972-502550555
SOURCE EZbra Advanced Wound Care Ltd.
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All